| We are a holding company named Eurand N.V. (formerly known as Eurand B.V., and
before that, Eurand Pharmaceuticals Holdings B.V.) and were incorporated in The
Netherlands as a private company with limited liability in 1984. We were
converted into a Dutch public limited liability company by notarial deed of
conversion executed November 30, 2006. In May 2007, we completed an initial
public offering of our ordinary shares in the United States and our ordinary
shares began trading on the NASDAQ Global Market. Our principal executive
offices are located at Olympic Plaza, Fred. Roeskestraat 123, 1076 EE Amsterdam,
The Netherlands, telephone +31 20-673 2744. We have operating subsidiaries
organized in the United States, Italy, France and Ireland. A list of our
subsidiaries as of December 31, 2007 is set forth in Exhibit 8 to this Annual
Report on Form 20-F. |
